Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses
- PMID: 23077237
- PMCID: PMC3589927
- DOI: 10.1093/jrr/rrs089
Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses
Abstract
We investigated the applicability of the repairable-conditionally repairable (RCR) model and the multi-target (MT) model to dose conversion in high-dose-per-fraction radiotherapy in comparison with the linear-quadratic (LQ) model. Cell survival data of V79 and EMT6 single cells receiving single doses of 2-12 Gy or 2 or 3 fractions of 4 or 5 Gy each, and that of V79 spheroids receiving single doses of 5-26 Gy or 2-5 fractions of 5-12 Gy, were analyzed. Single and fractionated doses to actually reduce cell survival to the same level were determined by a colony assay. Single doses used in the experiments and surviving fractions at the doses were substituted into equations of the RCR, MT and LQ models in the calculation software Mathematica, and each parameter coefficient was computed. Thereafter, using the coefficients and the three models, equivalent single doses for the hypofractionated doses were calculated. They were then compared with actually-determined equivalent single doses for the hypofractionated doses. The equivalent single doses calculated using the RCR, MT and LQ models tended to be lower than the actually determined equivalent single doses. The LQ model seemed to fit relatively well at doses of 5 Gy or less. At 6 Gy or higher doses, the RCR and MT models seemed to be more reliable than the LQ model. In hypofractionated stereotactic radiotherapy, the LQ model should not be used, and conversion models incorporating the concept of the RCR or MT models, such as the generalized linear-quadratic models, appear to be more suitable.
Figures


Similar articles
-
Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study.Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):482-8. doi: 10.1016/j.ijrobp.2008.12.093. Int J Radiat Oncol Biol Phys. 2009. PMID: 19735872
-
Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1538-43. doi: 10.1016/j.ijrobp.2011.05.034. Int J Radiat Oncol Biol Phys. 2011. PMID: 22115556
-
Applicability of the linear-quadratic model to single and fractionated radiotherapy schedules: an experimental study.J Radiat Res. 2014 May;55(3):451-4. doi: 10.1093/jrr/rrt138. Epub 2013 Dec 17. J Radiat Res. 2014. PMID: 24351457 Free PMC article.
-
Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data.Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):385-93. doi: 10.1016/j.ijrobp.2011.06.1990. Epub 2012 Jan 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 22265460 Free PMC article. Review.
-
Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model.J Radiat Res. 2012;53(1):1-9. doi: 10.1269/jrr.11095. Epub 2011 Oct 14. J Radiat Res. 2012. PMID: 21997195 Review.
Cited by
-
Clinical applicability of biologically effective dose calculation for spinal cord in fractionated spine stereotactic body radiation therapy.Radiol Oncol. 2015 Mar 25;49(2):185-91. doi: 10.1515/raon-2015-0008. eCollection 2015 Jun. Radiol Oncol. 2015. PMID: 26029031 Free PMC article.
-
Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis.J Radiat Res. 2014 May;55(3):575-82. doi: 10.1093/jrr/rrt146. Epub 2014 Jan 23. J Radiat Res. 2014. PMID: 24457315 Free PMC article. Clinical Trial.
-
Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus.J Neurooncol. 2016 Jun;128(2):267-75. doi: 10.1007/s11060-016-2105-1. Epub 2016 Mar 9. J Neurooncol. 2016. PMID: 26961771
-
Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects.Radiat Oncol. 2017 Jan 19;12(1):24. doi: 10.1186/s13014-016-0750-3. Radiat Oncol. 2017. PMID: 28107823 Free PMC article. Review.
-
Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer.J Radiat Res. 2014 May;55(3):494-501. doi: 10.1093/jrr/rrt124. Epub 2013 Oct 17. J Radiat Res. 2014. PMID: 24135154 Free PMC article. Clinical Trial.
References
-
- Kondziolka D, Flickinger J-C, Dade Lunsford L. Clinical research in stereotactic radiosurgery: lessons learned from over 10,000 cases. Neurol Res. 2011;33:792–802. - PubMed
-
- Shibamoto Y, Sugie C, Iwata H. Radiotherapy for metastatic brain tumors. Int J Clin Oncol. 2009;14:281–8. - PubMed
-
- Shibamoto Y, Hashizume C, Baba F, et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer. A multicenter study. Cancer. 2012;118:2078–84. - PubMed
-
- Fowler J-F. Review: total doses in fractionated radiotherapy – implications of new radiobiological data. Int J Radiat Biol. 1984;46:103–20. - PubMed
-
- Fowler J-F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62:679–94. - PubMed